Skip to main content
. Author manuscript; available in PMC: 2017 Nov 28.
Published in final edited form as: JAMA Psychiatry. 2014 Nov;71(11):1287–1295. doi: 10.1001/jamapsychiatry.2014.1242

Table 1.

Baseline Comparison of Treatment Groups

Characteristic Groupa Test
Statisticb
P Value
All (N = 151) IPT (n = 77) CGT (n = 74)
Age, mean (SD) 66.1 (8.9) 66.5 (8.8) 65.7 (9.0)   0.56 .57
Male sex    28 (18.5)    16 (20.8)    12 (16.2)   0.52 .47
Race/ethnicity
 White  130 (86.1)    68 (88.3)    62 (83.8)   0.65 .42
 Hispanic or Latino    12 (7.9)      8 (10.4)      4 (5.4)   1.28 .26
Educational level
 High school or less    16 (10.6)    12 (15.6)      4 (5.4)   7.83 .05
 Partial college    28 (18.5)      9 (11.7)    19 (25.7)
 Completed college    28 (18.5)    14 (18.2)    14 (18.9)
 Postgraduate    79 (52.3)    42 (54.5)    37 (50.0)
Marital status
 Never married    26 (17.2)    13 (16.9)    13 (17.6)   1.18 .76
 Married    29 (19.2)    17 (22.1)    12 (16.2)
 Separated/divorced    25 (16.6)    11 (14.3)    14 (18.9)
 Widowed (not remarried)    71 (47.0)    36 (46.8)    35 (47.3)
Person who died
 Spouse/partner    70 (46.4)    38 (49.4)    32 (43.2)   1.96 .58
 Parent    41 (27.2)    22 (28.6)    19 (25.7)
 Child    28 (18.5)    11 (14.3)    17 (23.0)
 Other    12 (7.9)      6 (7.8)      6 (8.1)
Violent death    20 (13.2)    10 (13.0)    10 (13.5)   0.01 .92
Time since loss, median (range), y   3.2 (0.5–45.3)   2.7 (0.5–38.1)   3.9 (0.5–45.3) z = 0.39 .69
MDD
 Current    69 (45.7)    33 (42.9)    36 (48.6)   0.51 .48
 Lifetime 102 (67.5)    51 (66.2)    51 (68.9)   0.12 .72
Panic disorder
 Current    18 (11.9)      7 (9.1)    11 (14.9)   1.20 .27
 Lifetime    28 (18.5)    10 (13.0)    18 (24.3)   3.21 .07
PTSD
 Current    23 (15.2)      7 (9.1)    16 (21.6)   4.59 .03
 Lifetime    31 (20.5)    11 (14.3)    20 (27.0)   3.75   .046
Current generalized anxiety    37 (24.5)    20 (26.0)    17 (23.0)   0.18 .67
ICG score, mean (SD)c 46.1 (9.4) 46.0 (9.7) 46.1 (9.1) −0.09 .93
WSAS score, mean (SD)d 22.0 (10.3) 21.8 (10.0) 22.3 (10.8) −0.27 .79
GRAQ score, mean (SD)e 23.9 (13.4) 23.9 (14.1) 23.9 (12.7) −0.02 .99
BDI score, mean (SD)f 21.3 (9.0) 20.5 (8.3) 22.4 (9.7) −1.22 .23
Suicidal thinking since the CG-related death    90 (59.6)    44 (57.1)    46 (63.0)   0.54 .46
CGI severity rating
 Normal      0      0      0   1.93 .59
 Borderline ill      0      0      0
 Mildly ill      2 (1.5)      2 (2.9)      0
 Moderately ill    46 (34.8)    23 (33.8)    23 (35.9)
 Markedly ill    78 (59.1)    40 (58.8)    38 (59.4)
 Severely ill      6 (4.5)      3 (4.4)      3 (4.7)
Antidepressant use    33 (21.9)    15 (19.5)    18 (24.3)   0.52 .47
Anxiolytic use    24 (15.9)    12 (15.6)    12 (16.2)   0.01 .92
Nonpsychotropic prescription medications used, No.
 Mean      2.1      2.1      2.2 −0.16 .87
 Median (range)      1 (0–10)      1 (0–8)      2 (0–10)
Psychotropic prescription medications used, No.
 Mean        0.7        0.7        0.8 −0.75 .46
 Median (range)      0 (0–5)      0 (0–5)   0.5 (0–4)
Use of psychotropic medicines    67 (44.4)    30 (39.0)    37 (50.0)   1.86 .17
MMSE total score, mean (SD) 28.2 (1.6) 28.1 (1.6) 28.2 (1.6) −0.23 .82

Abbreviations: BDI, Beck Depression Inventory; CG, complicated grief; CGI, Clinical Global Impression Scale; CGT, CG treatment; GRAQ, Grief-Related Avoidance Questionnaire; ICG, Inventory of Complicated Grief; IPT, interpersonal psychotherapy; MDD, major depressive disorder; MMSE, Mini-Mental State Examination; PTSD, posttraumatic stress disorder; WSAS, Work and Social Adjustment Scale.

a

Unless otherwise indicated, data are expressed as number (percentage) of patients. Percentages have been rounded and might not total 100.

b

χ2 Tests were used to compare group differences at baseline for categorical outcomes. Two-sample t tests were used for normally distributed continuous outcomes; otherwise, Wilcoxon rank sum tests were used.

c

Total score range, 0 to 76.

d

Total score range, 0 to 40.

e

Total score range, 0 to 60.

f

Total score range, 0 to 63.

HHS Vulnerability Disclosure